Twist Bioscience (NASDAQ:TWST – Get Rating) had its target price reduced by Barclays from $32.00 to $20.00 in a research report released on Monday morning, The Fly reports. Several other research firms have also recently issued reports on TWST. The Goldman Sachs Group reduced their price objective on shares of Twist Bioscience from $43.00 to […]
Twist Bioscience (NASDAQ:TWST – Get Rating) had its target price lowered by Robert W. Baird from $29.00 to $18.00 in a report released on Monday, The Fly reports. A number of other research analysts have also recently weighed in on TWST. The Goldman Sachs Group dropped their price target on Twist Bioscience from $43.00 to […]
Twist Bioscience (NASDAQ:TWST – Get Rating) had its price target lowered by Barclays from $32.00 to $20.00 in a research report released on Monday morning, The Fly reports. A number of other analysts have also recently weighed in on the stock. The Goldman Sachs Group decreased their price target on shares of Twist Bioscience from […]
Twist Bioscience (NASDAQ:TWST – Get Rating) had its price target lowered by analysts at Robert W. Baird from $29.00 to $18.00 in a research report issued on Monday, The Fly reports. Robert W. Baird’s target price would suggest a potential upside of 33.14% from the stock’s current price. Several other equities analysts have also recently […]
Twist Bioscience (NASDAQ:TWST – Get Rating) and Scilex (NASDAQ:SCLX – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations. Profitability This table compares Twist Bioscience and Scilex’s net margins, […]